相关实验视频

Updated: Jan 18, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

误解变异DCLRE1B rs3761936与乳腺癌和宫癌风险的关联-A病例控制研究

Sarah Jafrin^1,2, Md Abdul Aziz^1,2,3, Md Abdul Barek^1,2,3

¹Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Sonapur, Bangladesh.

|September 8, 2025

概括

DCLRE1B rs3761936多态性与孟加拉妇女乳腺癌和宫癌风险增加有关. 这种基因变异可能作为这些癌症类型的生物标志物.

科学领域:

遗传学是一个遗传学.
在瘤学瘤学.
分子生物学分子生物学

背景情况:

在乳腺癌和宫癌患者中观察到DCLRE1B基因rs3761936多态.
了解癌症的遗传倾向对于早期发现和预防策略至关重要.

研究的目的:

调查DCLRE1B rs3761936多态与患乳腺癌和宫癌的风险之间的关联.
确定这种基因变异是否可以作为孟加拉国人口癌症易感性的生物标志物.

主要方法:

进行了一项病例控制研究,包括245名癌症患者和108名健康对照.
用高效的T-ARMS PCR方法进行基因型鉴定.
统计分析包括各种遗传模型来评估风险 (例如,添加剂,主导).

主要成果:

与对照组相比,癌症患者表现出更高的突变等位基因频率.
突变等位基因携带者在多种遗传模型 (例如,附加,主导) 中显著增加患乳腺癌的风险.
同样,在几种遗传模型中,具有突变异位基因的宫癌患者的风险明显增加.

结论:

DCLRE1B rs3761936多态性与乳腺癌的风险增加密切相关.
这种遗传变异也与孟加拉妇女子宫癌风险增加有显著联系.
这些发现表明DCLRE1B rs3761936可能是乳腺癌和宫癌的潜在遗传生物标志物.

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...